About the speaker: Manoja is a biotech executive with over 25 years of global expertise in leadership roles within regulatory affairs and quality assurance. He is responsible for leading change and transforming functional organizations across regional and cultural geographies. He previously worked for the companies Terumo, Smith + Nephew, as well as other smaller companies. He currently resides in Switzerland.

About the company: Becton Dickinson (BD) is an American multinational medical technology company headquartered in New Jersey. It was founded in 1897 and is one of the world’s largest medical technology companies. Their products include medical devices, diagnostics, therapeutics, and products for R&D. BD’s medical devices include needles, syringes, IV catheters, blood collection tubes, etc. They have manufacturing facilities in over 20 countries and a presence in over 50.

Revenue: 18.87 billion USD

Employees: 77,000